Dynamic Medical Technologies Inc. · TPEX:4138
Dynamic Medical Technologies — H1 2019 Earnings Presentation
22 slides from Dynamic Medical Technologies's earnings presentation, Sep 27, 2019
Slide 1: Dynamic Medical Technologies Inc. Investor Conference-2019
Dynamic Medical Technologies Inc. Investor Conference-2019 September 27, 2019 Symbol:4138
Slide 2: Disclaimer
Disclaimer This presentation is prepared according to the reviewed financial statements by CPA and the financial numbers hereby are based on IFRS, please refer to the published financial statements for full content. The presentation may contain forward-looking information and may differ materially f
Slide 3: Content outline
Content outline 1.公司概況(Corporate Overview) P.4 2.市場概況(Market Overview) P.7 3.營運概況(Business Overview) P.9 4.財務概況(Financial Overview) P.11 5.策略及展望(Strategies and Outlook) P.13 6.補充資料(Appendix) P.15 3
Slide 4: Corporate Overview
Corporate Overview 曜亞國際 •從台灣出發、 『光曜亞洲、放眼國際』 經營理念 •客戶滿意．快樂員工．幸福企業 ．美麗人生 使命 •誠信正直 團隊合作 當責創新 董事長 Chairman 傅輝東 Tony Fu 4
Slide 5: Top Provider of Medical Aesthetic Solutions in Asia
Top Provider of Medical Aesthetic Solutions in Asia Dynamic Medical Technologies Inc.(DMT),was established in 2003. Consisting of experienced experts in different fields, DMT earns high reputation from both suppliers and customers. Merged companies aim to build a complete medical beauty industry cha
Slide 6: Top Provider of Medical Aesthetic Solutions in Asia
Top Provider of Medical Aesthetic Solutions in Asia DMT is in the leading edge of the medical aesthetic market and has successful created many trend products of the time, such as IPL, Skin-toning laser (C6), Fraxel, Ulthera, Picoway, vaginal lasers—Fotona Smooth and Viveve serial. Looking ahead, in
Slide 7: Market Overview
Market Overview According to the Asian-Pacific Market Study issued by Medical Insight, Inc. in Jan. 2019, total Asian sales of all aesthetic products and equipment reached US$2.1 billion in 2017 and are expected to increase by 13.2% per year through 2022. Furthermore, medical aesthetic market can be
Slide 8: Products Distributed
Products Distributed Energy- Based Device Body RF & Contouring HIFU Skin Imagining Dermal System Filler Skin/Hair Care 8
Slide 9: Business Overview
Business Overview 2018 DMT’s annual consolidation Revenue was over NT$1.1 billion. The main source of operating income is medical beauty equipment sales, accounting for about 33%; medical beauty consumables and parts sales, accounting for about 54%, and maintenance income and other, accounting for a
Slide 10: Operating Revenue
1,400,000 OPERATING REVENUE The 2018 net profit of the company was lower than 1,156,622 1,164,815 Unit：NTD$K the year of 2017, mainly due to the decreased of 1,200,000 gross profit rate which influenced by the 171,248 15% 131,105 11% 1,000,000 adjustment evaluation of inventory. 209,662 18% 237,688
Slide 11: Financial Overview
Financial Overview 1,214,814 1,156,622 1,164,815 Operating Revenue Gross Profit 405,842 Unit:NTD$K 370,803 Unit:NTD$K 336,258 614,520 605,873 182,864 172,468 33% 32% 29% 30% 28% 2016 2017 2018 2018H1 2019H1 2016 2017 2018 2018H1 2019H1 Operating Gross Profit 405,842 370,803 336,258 182,864 172,468 1
Slide 12: Profit Before Income Tax and Net Profit for the year
Profit Before Income Tax Net Profit for the year 250,000 160,000 148,564 143,318 182,935 Unit:NTD$K 175,606 140,000 200,000 30,110 30,240 122,282 Unit:NTD$K 120,000 17,307 150,000 142,423 9,418 100,000 82,213 85,476 80,000 100,000 194,682 194,093 69,757 67,937 8,082 9,823 9,239 60,000 118,454 133,00
Slide 13: Strategies and Outlook
Strategies and Outlook Long-Term Planning Mid-Term Planning Being a product leader in the medical cosmetology Hya-Dermis Brand market Management As a market leader, All-round one-stop beauty continue to lead Leading therapy service the market for beauty Short-Term Planning -EB Medytox_Neuron
Slide 14: Create a beauty life map
Crate a beauty life map 佳美(仁愛) CYJ(仁愛) CYJ(古亭) 佳美(大直) CYJ(永和) CYJ(板橋) CYJ(新莊) CYJ(桃園) Area 佳美(EB) 曜胜(CYJ) CYJ(新竹) North area 2 8 CYJ(竹北) Middle area 1 1 佳美(台中) South area 1 2 CYJ(台中) Total 4 11 CYJ(台南) 佳美(高雄) CYJ(高雄) 14
Slide 15: Appendix
Appendix Unit：NTD$K 2017/12/31 2018/12/31 2019/6/30 Cash and cash equivalents 925,464 868,885 742,193 Debt investments with no active market - current 330,600 180,020 390,520 Notes receivable & Trade receivables 162,130 198,534 213,826 Inventories 385,709 320,097 244,065 Other current assets 26,843
Slide 16: Liabilities and equity
Unit：NTD$K 2017/12/31 2018/12/31 2019/6/30 Notes payable & Trade payables 104,460 69,397 56,163 Other payables 183,220 168,846 264,920 long-term liabilities-current portion 299,606 - - contract liability 274,764 306,655 261,952 Other current liabilities 30,160 32,518 60,918 Total current liabilities
Slide 17: Income statement
Unit：NTD$K 2017 2018 2019H1 AMT % AMT % AMT % OPERATING REVENUE 1,156,622 100.00 1,164,815.00 100.71 605,873.00 98.59 OPERATING COSTS 785,819 67.94 828,557.00 71.64 433,405.00 70.53 GROSS PROFIT 370,803 32.06 336,258.00 29.07 172,468.00 28.07 OPERATING EXPENSES 176,710 15.28 203,253.00 17.57 86,398.
Slide 18: Cash flows from operating activities
Unit：NTD$K 2017 2018 2019H1 Cash flows from operating activities: Profit before tax 175,606 142,423 85,476 Total adjustments to reconcile profit 37,778 33,669 32,628 Accounts receivable 40,207 (26,978) (13,768) Other receivable 7,076 (64) (341) Inventories (137,988) 43,969 58,480 Accounts payable 59
Slide 19: Cash flows from investing activities
Unit：NTD$K 2017 2018 2019H1 Cash flows from investing activities: Acquisition of financial assets at amortised - (130,000) (270,520) cost Proceeds from disposal of financial assets at - 279,900 60,000 amortised cost Acquisition investments in debt instrument (128,600) - - without active market Proce
Slide 20: Cash flows from financing activities
Unit：NTD$K 2017 2018 2019H1 Cash flows from financing activities: Repayments of bonds - (300,000) - Cash dividends paid (106,800) (102,000) - Acquisition of ownership interests in (10,000) - - subsidiaries Other (48) (26,052) (12,922) Net cash flows used in financing activities (116,848) (428,052) (
Slide 21: On the Top, Aiming High
On the Top, Aiming High Accumulated years of experience, DMT. is in the leading edge of the medical aesthetic market by means of sophisticated sales and marketing forces and dedicated service and management team. With successful integration, DMT has achieved vertical integration of medical aesthetic
Slide 22: Dynamic Medical Technologies Inc.
© wees ae CYNAMIC MEDICAL TECHNOLOGIES INC. | BRAKES | BRRRAERA | BATRA E | BSLBATHRE | SRRBARRE | international medical aestheiics equipment selling Medical aesthelics equipment nainlenance Dermal filler selling n-egrated marketing services for medical aesthetics Professional hair growtn system sel
Dynamic Medical Technologies — H1 2019 Earnings Presentation on 6ix